Overview

Luteal Support and Intrauterine Insemination (IUI) With Clomiphene Citrate

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to assess the effect of luteal phase supplement (LPS) on pregnancy rate in IUI cycles stimulated with clomiphene citrate.
Phase:
N/A
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Universitair Ziekenhuis Brussel
Treatments:
Citric Acid
Clomiphene
Enclomiphene
Progesterone
Zuclomiphene
Criteria
Inclusion Criteria:

- Age ≤ 36 years

- Body mass index between 18 and 29

- Presence of both ovaries

- Basal levels of estradiol (≤ 80 pg/ml) and progesterone (≤ 1.6ng/ml) on day one of the
cycle and a day three FSH level of <12IU/L

- Patients can enter the study only once.

- Only the first IUI attempt will be included ( at the 2nd and 3 rd attempt progesterone
could be administrated if it is necessary but these attempts will be excluded from the
study)

- Normal HSG (maximum 3 months prior starting the stimulation).

- Donor sperm can be included

Exclusion Criteria:

- Polycystic ovarian syndrome (Rotterdam criteria)

- Endometriosis(≥AFS III)